Could Biden Administration’s Proposal To Cover Weight Loss Drugs Lead to ‘Surge in the National Debt’?

‘I suspect that the cost of this single executive action will end up exceeding all the savings that DOGE generates put together,’ says one observer.

Mario Tama/Getty Images
The Biden administration is considering having Medicare and Medicaid cover Ozempic and other weight loss drugs. Mario Tama/Getty Images

The Biden administration’s latest proposal to allow Medicare and Medicaid to cover weight loss drugs such as Ozempic and Wegovy could bring expanded coverage for millions of Americans — and with it, a hefty price tag for taxpayers. 

The White House says the proposed regulation, announced Tuesday, would help 3.4 million Americans with Medicare and nearly 4 million with Medicare. While the health insurance programs currently cover the use of anti-obesity medications for conditions such as diabetes, the new proposal aims to cover them for obesity as well. 

Enter your email to read this article.

Get 2 free articles when you subscribe.

or
Have an account? This is also a sign-in form.
By continuing you agree to our Privacy Policy and Terms of Service.
Advertisement
The New York Sun

© 2025 The New York Sun Company, LLC. All rights reserved.

Use of this site constitutes acceptance of our Terms of Use and Privacy Policy. The material on this site is protected by copyright law and may not be reproduced, distributed, transmitted, cached or otherwise used.

The New York Sun

Sign in or  Create a free account

or
By continuing you agree to our Privacy Policy and Terms of Use